Abbott Laboratories (ABT) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10% |
| Dec 31, 2025 | 0.29% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -4.80% |
| Mar 31, 2025 | 6.10% |
| Dec 31, 2024 | 10.65% |
| Sep 30, 2024 | 6.75% |
| Jun 30, 2024 | 2.64% |
| Mar 31, 2024 | 3.51% |
| Dec 31, 2023 | 10.08% |
| Sep 30, 2023 | 9.61% |
| Jun 30, 2023 | 11.21% |
| Mar 31, 2023 | 6.68% |
| Dec 31, 2022 | 12.07% |
| Sep 30, 2022 | 12.17% |
| Jun 30, 2022 | 8.25% |
| Mar 31, 2022 | 3.37% |
| Dec 31, 2021 | 13.99% |
| Sep 30, 2021 | 8.12% |
| Jun 30, 2021 | 10.83% |
| Mar 31, 2021 | 10.32% |
| Dec 31, 2020 | 22.32% |
| Sep 30, 2020 | 3.83% |
| Jun 30, 2020 | 24.34% |
| Mar 31, 2020 | 8.90% |
| Dec 31, 2019 | 8.62% |
| Sep 30, 2019 | 7.68% |
| Jun 30, 2019 | 12.65% |
| Mar 31, 2019 | 5.61% |
| Dec 31, 2018 | 9.04% |
| Sep 30, 2018 | 5.03% |
| Jun 30, 2018 | 0.48% |
| Mar 31, 2018 | 0.07% |
| Dec 31, 2017 | -2.21% |
| Sep 30, 2017 | -13.10% |
| Jun 30, 2017 | -9.72% |
| Mar 31, 2017 | -9.71% |
| Dec 31, 2016 | 3.07% |
| Sep 30, 2016 | -7.15% |
| Jun 30, 2016 | -7.91% |
| Mar 31, 2016 | -9.11% |
| Dec 31, 2015 | -3.17% |
| Sep 30, 2015 | 14.92% |
| Jun 30, 2015 | -4.61% |
| Mar 31, 2015 | -0.84% |
| Dec 31, 2014 | 3.18% |
| Sep 30, 2014 | -3.37% |